Trends in Costs of Care and Utilization for Medicaid Patients With Diabetes in Accountable Care Communities.
Journal
Medical care
ISSN: 1537-1948
Titre abrégé: Med Care
Pays: United States
ID NLM: 0230027
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
8
8
2020
Statut:
ppublish
Résumé
Medicaid beneficiaries with diabetes have complex care needs. The Accountable Care Communities (ACC) Program is a practice-level intervention implemented by UnitedHealthcare to improve care for Medicaid beneficiaries. We examined changes in costs and utilization for Medicaid beneficiaries with diabetes assigned to ACC versus usual care practices. Interrupted time series with concurrent control group analysis, at the person-month level. The ACC was implemented in 14 states, and we selected comparison non-ACC practices from those states to control for state-level variation in Medicaid program. We adjusted the models for age, sex, race/ethnicity, comorbidities, seasonality, and state-by-year fixed effects. We examined the difference between ACC and non-ACC practices in changes in the time trends of expenditures and hospital and emergency room utilization, for the 4 largest categories of Medicaid eligibility [Temporary Assistance to Needy Families, Supplemental Security Income (without Medicare), Expansion, Dual-Eligible]. Eligibility and claims data from Medicaid adults with diabetes from 14 states between 2010 and 2016, before and after ACC implementation. Analyses included 1,200,460 person-months from 66,450 Medicaid patients with diabetes. ACC implementation was not associated with significant changes in outcome time trends, relative to comparators, for all Medicaid categories. Medicaid patients assigned to ACC practices had no changes in cost or utilization over 3 years of follow-up, compared with patients assigned to non-ACC practices. The ACC program may not reduce costs or utilization for Medicaid patients with diabetes.
Sections du résumé
BACKGROUND/OBJECTIVES
Medicaid beneficiaries with diabetes have complex care needs. The Accountable Care Communities (ACC) Program is a practice-level intervention implemented by UnitedHealthcare to improve care for Medicaid beneficiaries. We examined changes in costs and utilization for Medicaid beneficiaries with diabetes assigned to ACC versus usual care practices.
RESEARCH DESIGN
Interrupted time series with concurrent control group analysis, at the person-month level. The ACC was implemented in 14 states, and we selected comparison non-ACC practices from those states to control for state-level variation in Medicaid program. We adjusted the models for age, sex, race/ethnicity, comorbidities, seasonality, and state-by-year fixed effects. We examined the difference between ACC and non-ACC practices in changes in the time trends of expenditures and hospital and emergency room utilization, for the 4 largest categories of Medicaid eligibility [Temporary Assistance to Needy Families, Supplemental Security Income (without Medicare), Expansion, Dual-Eligible].
SUBJECTS/MEASURES
Eligibility and claims data from Medicaid adults with diabetes from 14 states between 2010 and 2016, before and after ACC implementation.
RESULTS
Analyses included 1,200,460 person-months from 66,450 Medicaid patients with diabetes. ACC implementation was not associated with significant changes in outcome time trends, relative to comparators, for all Medicaid categories.
CONCLUSIONS
Medicaid patients assigned to ACC practices had no changes in cost or utilization over 3 years of follow-up, compared with patients assigned to non-ACC practices. The ACC program may not reduce costs or utilization for Medicaid patients with diabetes.
Identifiants
pubmed: 32412952
doi: 10.1097/MLR.0000000000001318
pii: 00005650-202006001-00008
pmc: PMC8260093
mid: NIHMS1572792
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
S40-S45Subventions
Organisme : NCCDPHP CDC HHS
ID : U18 DP006128
Pays : United States
Organisme : ACL HHS
ID : U18DP006128
Pays : United States
Références
Annu Rev Public Health. 1993;14:43-68
pubmed: 8323597
Curr Diab Rep. 2018 Feb 5;18(2):8
pubmed: 29399715
Health Aff (Millwood). 2015 Jan;34(1):78-86
pubmed: 25561647
Med Care. 2017 Mar;55(3):207-214
pubmed: 27579910
J Ambul Care Manage. 2008 Oct-Dec;31(4):319-29
pubmed: 18806592
Diabetes Care. 2001 Oct;24(10):1821-33
pubmed: 11574449
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Med Care. 2020 Jun;58 Suppl 6 Suppl 1:S14-S21
pubmed: 32412949
Inquiry. 2019 Jan-Dec;56:46958019838118
pubmed: 30947608
Health Aff (Millwood). 2014 Apr;33(4):700-7
pubmed: 24622387
BMC Fam Pract. 2015 Feb 06;16:12
pubmed: 25655401
Med Care. 2008 May;46(5):489-96
pubmed: 18438197
Curr Diab Rep. 2018 Nov 20;18(12):146
pubmed: 30456479
Health Aff (Millwood). 2015 Jul;34(7):1180-7
pubmed: 26153313
Milbank Q. 2016 Sep;94(3):626-53
pubmed: 27620686
Annu Rev Public Health. 2017 Mar 20;38:39-56
pubmed: 28125392
Health Aff (Millwood). 2012 Jan;31(1):159-67
pubmed: 22232106
Ann Emerg Med. 2012 Jul;60(1):4-10.e2
pubmed: 22418570
J Clin Pharm Ther. 2002 Aug;27(4):299-309
pubmed: 12174032
Diabetol Metab Syndr. 2016 Jan 22;8:7
pubmed: 26807158
Issue Brief Cent Stud Health Syst Change. 2009 Dec;(129):1-4
pubmed: 20198754
Med Care. 2016 May;54(5):483-9
pubmed: 26908088
BMC Fam Pract. 2018 Jan 9;19(1):11
pubmed: 29316889